Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

Proteome Analysis

Below the proteome analysis is presented. The analysis methods are presented in the paper Propagating Differential Gene Expression in Protein Interaction Networks. If you are interested in the most reliable results choose the

  • value_type as 'ranked' since this provides a very robust analysis method.
  • intercation map as 'high confidence'
  • network_comparison type as 'Divided' since this leads to a natural grouping of similar proteins
  • filtered as 'true' since this will only use the microarray measurements that have a sufficiently large confidence level.

    • Navigation/Query Panel:
    Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
    Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
    Results: HTML CSV LaTeX Showing element 1508 to 1557 of 6456 in total 
    Value Type: Ranked
    Interaction Map: High confidence
    Filtered: 1
    
\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
754\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
suppressor of actin mutations 2-like isoform b; dj1033b10.5. [source:refseq;acc:nm\_022553]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.946\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.225\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10.279\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
755\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein sa (p40) (34/67 kda laminin receptor) (colon carcinoma laminin-binding protein) (nem/1chd4) (multidrug resistance- associated protein mgr1-ag). [source:swissprot;acc:p08865]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
224.244\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.511\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10.267\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
uridine 5'-monophosphate synthase (ump synthase) [includes: orotate phosphoribosyltransferase (ec 2.4.2.10) (oprtase); orotidine 5'- phosphate decarboxylase (ec 4.1.1.23) (ompdecase)]. [source:swissprot;acc:p11172]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.434\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.583\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04968\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
756\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s21. [source:swissprot;acc:p35265]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.244\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.511\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10.267\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cleft lip and palate associated transmembrane protein 1. [source:refseq;acc:nm\_001294]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
224.434\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
235.583\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04968\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
757\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bactericidal permeability-increasing protein precursor (bpi) (cap 57). [source:swissprot;acc:p17213]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytoplasmic antiproteinase 3 (cap3) (cap-3) (protease inhibitor 9) (serpin b9). [source:swissprot;acc:p50453]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
224.244\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
234.511\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
10.267\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
758\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
maspin precursor (protease inhibitor 5). [source:swissprot;acc:p36952]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
phospholipid transfer protein precursor (lipid transfer protein ii). [source:swissprot;acc:p55058]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.434\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.583\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04968\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
759\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bomapin (protease inhibitor 10) (serpin b10). [source:swissprot;acc:p48595]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.244\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.511\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10.267\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
osteoclast stimulating factor 1. [source:swissprot;acc:q92882]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
231.809\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
243.289\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04952\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
760\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
plasminogen activator inhibitor-2 precursor (pai-2) (placental plasminogen activator inhibitor) (monocyte arg-serpin) (urokinase inhibitor). [source:swissprot;acc:p05120]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.244\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.511\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10.267\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
upf0202 protein kiaa1709. [source:swissprot;acc:q9h0a0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
246.055\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.458\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04946\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
761\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
serpin b11. [source:swissprot;acc:q96p15]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.244\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.511\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10.267\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
signal transduction protein cbl-b (sh3-binding protein cbl-b). [source:swissprot;acc:q13191]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.325\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.303\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0493\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
762\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cbl e3 ubiquitin protein ligase (ec 6.3.2.-) (signal transduction protein cbl) (proto-oncogene c-cbl). [source:swissprot;acc:p22681]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
213.256\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.237\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
placental thrombin inhibitor (cytoplasmic antiproteinase) (cap) (protease inhibitor 6) (pi-6). [source:swissprot;acc:p35237]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
224.244\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
234.511\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
10.267\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
763\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytoplasmic antiproteinase 2 (cap2) (cap-2) (protease inhibitor 8) (serpin b8). [source:swissprot;acc:p50452]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative n6-dna-methyltransferase (ec 2.1.1.-) (protein pred28) (m.hsahemk2p). [source:swissprot;acc:q9y5n5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.091\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04901\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
764\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
leukocyte elastase inhibitor (lei) (monocyte/neutrophil elastase inhibitor) (m/nei) (ei). [source:swissprot;acc:p30740]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.244\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.511\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10.267\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
u4/u6-associated rna splicing factor. [source:refseq;acc:nm\_004698]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.082\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.707\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04901\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
765\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 3 subunit 9 (eif-3 eta) (eif3 p116) (eif3 p110) (eif3b). [source:swissprot;acc:p55884]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.067\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
232.805\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10.262\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hemk protein homolog (ec 2.1.1.-) (m.hsahemkp). [source:swissprot;acc:q9y5r4]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
229.045\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.343\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04901\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
766\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein tara (trio-associated repeat on actin) (hrihfb2122). [source:swissprot;acc:q9h2d6]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
213.804\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.226\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04875\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sorting nexin 6 (traf4-associated factor 2). [source:swissprot;acc:q9unh7]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.191\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.332\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10.141\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
767\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 14.5 kda polypeptide (ec 2.7.7.6) (rpb9) (rpb14.5). [source:swissprot;acc:p36954]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
228.563\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
238.668\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10.105\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rho interacting protein 3. [source:refseq;acc:nm\_015134]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.803\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.224\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04874\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
768\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dnaj homolog subfamily b member 4 (heat shock 40 kda protein 1 homolog) (heat shock protein 40 homolog) (hsp40 homolog). [source:swissprot;acc:q9udy4]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
210.946\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.225\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04873\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
signal transduction protein cbl-b (sh3-binding protein cbl-b). [source:swissprot;acc:q13191]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.325\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.303\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10.022\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
769\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cab2. [source:refseq;acc:nm\_033419]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.946\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.225\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04873\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cbl e3 ubiquitin protein ligase (ec 6.3.2.-) (signal transduction protein cbl) (proto-oncogene c-cbl). [source:swissprot;acc:p22681]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.256\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.237\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10.019\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
770\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dnaj homolog subfamily b member 5 (heat shock protein hsp40-3) (heat shock protein cognate 40) (hsc40) (hsp40-2). [source:swissprot;acc:o75953]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.946\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.225\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04873\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related gtp binding a; ras-related gtp-binding protein. [source:refseq;acc:nm\_006570]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
771\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dnaj homolog subfamily b member 1 (heat shock 40 kda protein 1) (heat shock protein 40) (hsp40) (dnaj protein homolog 1) (hdj-1). [source:swissprot;acc:p25685]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.946\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.225\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04873\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related gtp binding c; rag c protein. [source:refseq;acc:nm\_022157]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
772\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic peptide chain release factor subunit 1 (erf1) (eukaryotic release factor 1) (tb3-1) (c11 protein). [source:swissprot;acc:p46055]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.946\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.225\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04873\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related gtp binding b short isoform; gtp-binding protein ragb. [source:refseq;acc:nm\_006064]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
59\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
49\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
10\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
773\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
anillin, actin binding protein (scraps homolog, drosophila); anillin (drosophila scraps homolog), actin binding protein. [source:refseq;acc:nm\_018685]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
suppressor of actin mutations 2-like isoform b; dj1033b10.5. [source:refseq;acc:nm\_022553]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.946\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.225\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04873\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
774\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial 28s ribosomal protein s2 (mrp-s2) (cgi-91). [source:swissprot;acc:q9y399]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.716\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
231.501\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9.785\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
multiple coagulation factor deficiency 2; neural stem cell derived neuronal survival protein; multiple coagulation factor deficiency protein 2. [source:refseq;acc:nm\_139279]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.996\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.535\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04854\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
775\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone deacetylase 2 (hd2). [source:swissprot;acc:q92769]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
226.003\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.541\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
u3 snornp protein 4 homolog. [source:refseq;acc:nm\_033416]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.676\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
231.453\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9.777\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
776\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj153g14.2 (possible ca binding protein similar to nefa) (fragment). [source:sptrembl;acc:q9ujn8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.996\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.535\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04854\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sequestosome 1; ubiquitin-binding protein p62; phosphotyrosine independent ligand for the lck sh2 domain p62. [source:refseq;acc:nm\_003900]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.965\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.404\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9.561\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
777\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone deacetylase 1 (hd1). [source:swissprot;acc:q13547]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.989\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.53\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04853\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nonspecific lipid-transfer protein, mitochondrial precursor (nsl-tp) (sterol carrier protein 2) (scp-2) (sterol carrier protein x) (scp-x) (scpx). [source:swissprot;acc:p22307]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.965\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.404\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9.561\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
778\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-catenin (pro2286). [source:swissprot;acc:p35222]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
224.445\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.894\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9.551\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sorting nexin 6 (traf4-associated factor 2). [source:swissprot;acc:q9unh7]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.191\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.332\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04848\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\parbox{\wcA}{\vspace{3pt}\noindent
779\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
deoxycytidylate deaminase (ec 3.5.4.12) (dcmp deaminase). [source:swissprot;acc:p32321]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
230.516\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
241.641\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04826\vspace{3pt}}\\\hline
nd{longtable}

    Legend:
    - Rank is the rank after comparing the two networks
    
 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
    
 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
    
 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
    
 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
    
 - Filtered specifies whether we only included the high confidence microarry measurements or not.
    - http://analysis.yellowcouch.org/